Delivery Order SPE2DB20D3104-SPE2DB24FV6Q3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,727.36, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 20, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,282.76 and a completion date of September 26, 2024. It is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.15 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 MG CAPSULE 30S, a generic medication. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,766.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562876774 ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,615.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the supply of ATOMOXETINE HCL 10 MG CAPSULE 30S, a medication. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $1,292.40 fixed-price delivery order is for the supply of 4564350703 - ATOMOXETINE HCL 40 MG CAPSULE 30S, with a completion date of April 23, 2024. Amerisourcebergen holds two larger Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DX24F1VUX) for the supply of 4565573039 - ATOMOXETINE HCL 10 MG CAPSULE 30S. The $1,090.47 firm fixed price contract has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is not set aside for any specific business type. As a large distributor of pharmaceutical products...
- This federal contract award, with an ID of SPE2DB20D3505|SPE2DB22FU1B2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,014.30 firm fixed-price delivery order is for the supply of 4557922882 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has a ceiling value of $1,854.72 and is a Firm Fixed Price Delivery Order. The funding agency is the Defense Logistics Agency (DLA), a defense agency that serves as a critical supplier of medical and...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV6Q3Delivery Order
This federal contract award is a delivery order (SPE2DB20D3104|SPE2DB24FV6Q3) worth $1,809.62, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564437085 ATOMOXETINE HCL 40 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the Department of Justice Federal Bureau of Investigation through a separate IDC valued at $750,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/29/24 |